A Randomized, Open-label, Single-dose, 2-Way Cross-over Study to Compare the Safety and the Pharmacokinetic Characteristics of the Co-administration of Rosuvastatin and Metformin SR and YH14755 and to Investigate the Effect of Food on the Pharmacokinetics of YH14755
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
Price : $35 *
At a glance
- Drugs Metformin/rosuvastatin (Primary) ; Metformin; Rosuvastatin
- Indications Hyperlipidaemia; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Yuhan
- 08 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2014 Planned primary completion date changed from 1 Aug 2014 to 1 Sep 2014.
- 26 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.